HIGHLIGHTS
- who: Cancer Questionnaire (Head et al. from the Institute of Medical and, Oral Medicine and Radiology have published the research: Review began 01/26/2023 Review ended 01/30/2023 Published 02/05/2023 u00a9 Copyright, in the Journal: (JOURNAL) of February/05,/2023
- what: The administration of EORTC QLQ-HN43 was found to be efficacious in our study on patients with OSCC.
- how: The authors considered only 12 months post-treatment and further changes in QOL will happen over a longer period.
SUMMARY
The study was performed to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.